A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.

Adaptate Biotherapeutics, a UK-based antibody-based therapeutics developer focused on oncology, has agreed to an acquisition by pharmaceutical firm Takeda for an undisclosed sum. Adaptate was spun out of GammaDelta Therapeutics, itself immunotherapy developer based on research at King’s College London and the Francis Crick Institute. Both Adaptate and GammaDelta also received support from charity Cancer Research UK.

Loewi, a Germany-based personalised nutrition provider spun out of TU Munich, has been acquired by healthtech producer Bioniq for an undisclosed sum.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Thierry Heles

Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
Email LinkedIn